Deep venous stenting in chronic iliac venous obstructive lesions: a single-center experience | ||||
| The Egyptian Journal of Surgery | ||||
| Volume 39, Issue 4, December 2020 PDF (2.47 MB) | ||||
| DOI: 10.4103/ejs.ejs_200_20 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Mohamed A.H. Taha; Haitham A. Hassan; Ayman E.H. Badawy; Bahgat A.H. Thabet | ||||
| Abstract | ||||
| Introduction Endovascular management for patients with chronic outflow lesions has been considered as an optimal alternative option for symptom control, as conservative compression therapy may fail later. The study aimed to determine the clinical outcomes and to evaluate the quality of life (QoL) improvement after recanalization and deep venous stenting in patients with postthrombotic syndrome and nonthrombotic iliac vein lesion in whom conventional treatment had failed. Patients and methods This study was conducted prospectively on 40 patients with chronic deep venous diseases (nonthrombotic iliac vein lesion or postthrombotic syndrome) and who presented to Vascular Surgery Department, Faculty of Medicine, Assiut, Egypt from July 2016 to September 2019. Results A total of 40 patients with 50 limbs (21 males; median age, 45.2 years, with range, 18–75 years) were included, and all had successful recanalization and stent deployment. A complete history and physical examination were performed for all included patients as well as assessment of daily activity improvements after endovenous procedures during postoperative follow-up visits at 2 weeks, 1.5, 3, 6, and 12 months. Deep venous recanalization with deployment of stents was medically successful in all 50 limbs with overall high patency (primary, assisted secondary, and secondary patency rates of 76, 88, and 92%, respectively). A statistically significant improvement in QoL scores (VEINESQOL/Sym scores) was observed in all patients as compared with the baseline at 2, 6, and 12 months after stenting (64.4, 69.2, and 73.4, respectively, <0.05) along with a significant decrease in both Villalta and Venous Clinical Severity Score scores from baseline compared with 2, 6, and 12 months after the treatment (7.3, 6.4, and 6.3, respectively, <0.0001 and 7.0, 6.4, and 6.2, respectively, <0.0001). Conclusions Our results confirm the significant effect of stenting on QoL of patients with chronic symptomatic iliofemoral venous obstructive lesions with high cumulative patency rate, making it a viable treatment option. | ||||
| Keywords | ||||
| nonthrombotic iliac vein lesion; obstructive; occlusions; outflow; postthrombotic syndrome; Stents; venous | ||||
|
Statistics Article View: 3 PDF Download: 1 |
||||
